Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Aug 24;12:1177271917726964. doi: 10.1177/1177271917726964

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2017

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 1. — Chondroitin sulfate (CS) reduces MCP-1 release from adipocytes stimulated by LPS. 3T3-L1 cells were differentiated into adipocytes and then stimulated with µg/mL of LPS. CS in physiologically relevant doses (100-200 µg/mL) produced a dose-dependent reduction in MCP-1 release from these cells. Mean MCP-1 (unadjusted for cell viability) was 8.4 ng/mL for control and 39.0 ng/mL for cells treated only with LPS. Bars represent mean + SD. n = 3 for each treatment group. LPS indicates lipopolysaccharides; MCP-1, monocyte chemoattractant protein-1.